Format

Send to

Choose Destination
Clin Nucl Med. 2012 Feb;37(2):e33-5. doi: 10.1097/RLU.0b013e3182335f33.

Assessment of rhabdoid brain tumor by F-18 FDG PET, C-11 methionine PET and MRI.

Author information

1
Nuclear Medicine CRC Mar, Hospital del Mar, Parc de Salut Mar, Barcelona, Spain. tonimefu@hotmail.com

Abstract

A 28-year-old man with headache, nausea, and decreased vision had a left parieto-occipital tumor demonstrated by MRI. Postradical resection and histology showed a solid mass containing rhabdoid cells, 10% positive for Ki-67. After completing chemotherapy and radiotherapy treatment, follow-up MRI revealed possible tumoral recurrence. Cerebral F-18 FDG PET revealed no pathologic uptake, and C-11 methionine PET showed a pathologic low uptake. These findings suggested recurrence of a mild-grade aggressiveness tumor, which was confirmed by a second neurosurgical resection.

PMID:
22228362
DOI:
10.1097/RLU.0b013e3182335f33
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Wolters Kluwer
Loading ...
Support Center